Human XEN-Like Stem Cell Culture for Long-Term Passage Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for new and/or improved methods for generating human stem cells, particularly human extraembryonic endoderm stem (XEN) cells, which can be maintained in culture for a significant number of passages and exhibit specific markers, as well as methods for producing trophoblast stem (TSC) and naïve pluripotent stem (nPSC) cells from in vitro-derived multi-layered cellular structures.
Innovation Solution
The production of human XEN-like cells involves culturing single cells dissociated from a multi-layered cellular structure or blastocyst-like structure on a feeder layer in the presence of leukemia inhibitory factor (LIF), a GSK-3 inhibitor, and Activin A, while TSCs are cultured on extracellular matrix proteins with a medium containing EGF, a ROCK inhibitor, and HDAC and TGF-β inhibitors, and nPSCs are cultured with MEK, PKC, and STAT3 activators.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If human XEN cells are derived from blastocysts using conventional methods, then the cells can be obtained, but they cannot be maintained in culture for a significant number of passages
Solution Approach 1:
The patent applies parameter changes by modifying culture medium composition (adding LIF, GSK-3 inhibitor, and Activin A), changing feeder layer conditions, and adjusting passage timing to enable long-term maintenance of XEN-like cells through multiple passages while maintaining their undifferentiated state and marker expression
Solution Approach 2:
The patent uses feeder layers as intermediary structures that provide essential growth factors and signaling molecules to support XEN-like cell survival and self-renewal, allowing the cells to be maintained in culture without direct embryo destruction
2Productivity
If transcription factor-mediated reprogramming is used to generate hiPSCs, then adult cells can be reprogrammed into pluripotent stem cells, but the process is complex and time-consuming
Solution Approach 1:
The patent extracts and isolates specific cell lineages (XEN, TSC, nPSC) from multi-layered cellular structures using lineage-specific markers and selective culture conditions, simplifying the reprogramming process by focusing on specific cell populations rather than using adult somatic cells
Solution Approach 2:
The patent performs preliminary differentiation of reprogrammed cells into specific lineages (XEN-like, TSC, or nPSC) before final characterization, allowing efficient generation of functionally relevant stem cell types through targeted culture conditions rather than requiring complex multi-step reprogramming
3Manufacturing precision
If conventional stem cell derivation methods are used, then stem cells can be obtained from blastocysts, but the methods do not produce cells that express specific lineage markers consistently
Solution Approach 1:
The patent applies local quality by providing lineage-specific culture conditions for each stem cell type (XEN cells receive LIF and Activin A for extraembryonic endoderm identity, TSC cells receive EGF and TGF-β inhibitors for trophoblast identity, nPSCs receive MEK and PKC activators for pluripotent identity), ensuring consistent marker expression and cellular identity for each population
Data Source
AI summary
The present invention relates to stem cells derived from a multi-layered cellular structure or blastocyst structure, compositions comprising the same, and methods for obtaining the same.